Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVS
NVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVS News
Novartis Acquires Myricx Bio for Up to $1.5 Billion
2d ago
NASDAQ.COM
Belgium Football Team Advances to Quarter-Finals
1d ago
CNBC
Novartis Acquires Myricx Bio for Up to $1.5B to Enhance Oncology Pipeline
2d ago
seekingalpha
Trump Awarded Inaugural FIFA Peace Prize Amid World Cup Drama
2d ago
CNBC
Vanguard Research Favors Value and International Stocks in AI Era
3d ago
NASDAQ.COM
Vanguard Sees AI Boosting Value Stocks Over Tech
3d ago
Fool
Comparative Analysis of International Stock ETFs
5d ago
NASDAQ.COM
Comparison of Core International Stock ETFs
5d ago
Fool
Novartis Gene Therapy Itvisma Approved by European Commission
5d ago
seekingalpha
Novartis Receives Approval for Itvisma Gene Therapy
6d ago
NASDAQ.COM
Novartis Secures EU Approval for Itvisma to Treat Spinal Muscular Atrophy
6d ago
NASDAQ.COM
ADMA Biologics Shows Promising Profitability Outlook
Jun 29 2026
NASDAQ.COM
SpaceX's $2 Trillion Valuation Faces Significant Hurdles Ahead
Jun 29 2026
Fool
Antares Therapeutics Partners with Novartis in $1.9B Cancer Drug Deal
Jun 24 2026
seekingalpha
NASDAQ 100 Pre-Market Activity Overview
Jun 24 2026
NASDAQ.COM
Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS
Jun 24 2026
Globenewswire
Show More News
